Kay Ahn
Impact in
- Geriatrics and Gerontology top 0.5%
- Sirtuins and Resveratrol in Medicine
- Pharmacology top 0.5%
- Cannabis and Cannabinoid Research
Papers in
- Pharmacology 11
- Cannabis and Cannabinoid Research 9
- Inflammatory mediators and NSAID effects 2
-
- Lipid metabolism and biosynthesis 5
- Co-authors
- Benjamin F. Cravatt (10 shared papers)Michele K. McKinney (2 shared papers)Douglas S. Johnson (7 shared papers)Brandon A. Pabst (4 shared papers)Marya B. Liimatta (5 shared papers)Robert S. Garofalo (1 shared paper)Michelle Pacholec (1 shared paper)Cory M. Stiff (4 shared papers)
- Journals
- Journal of Medicinal Chemistry (6 papers)Biochemistry (6 papers)Journal of Pharmacology and Experimental Therapeutics (3 papers)ACS Medicinal Chemistry Letters (2 papers)Bioorganic & Medicinal Chemistry Letters (2 papers)
- Partner nations
- United StatesBelgium
In The Last Decade
Kay Ahn
31 papers receiving 3k citations
Peers
Comparison fields: 5 of 94
- Geriatrics and Gerontology 480
- Pharmacology 1.2k
- Aging 61
- Biochemistry 134
- Organic Chemistry 333
Countries citing papers authored by Kay Ahn
This map shows the geographic impact of Kay Ahn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kay Ahn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kay Ahn more than expected).
Fields of papers citing papers by Kay Ahn
This network shows the impact of papers produced by Kay Ahn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kay Ahn. The network helps show where Kay Ahn may publish in the future.
Co-authors
The 25 scholars most cited alongside Kay Ahn, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 787 | |
| 2 | 2008 | 455 | |
| 3 | 2009 | 390 | |
| 4 | 2011 | 204 | |
| 5 | 2010 | 165 | |
| 6 | 2009 | 161 | |
| 7 | 2008 | 136 | |
| 8 | 2015 | 89 | |
| 9 | 2012 | 85 | |
| 10 | 2015 | 73 | |
| 11 | 2023 | 64 | |
| 12 | 2020 | 62 | |
| 13 | 2023 | 61 | |
| 14 | 2009 | 60 | |
| 15 | 2015 | 53 | |
| 16 | 2020 | 44 | |
| 17 | 2017 | 41 | |
| 18 | 2013 | 35 | |
| 19 | 2012 | 29 | |
| 20 | 2005 | 27 |
About Kay Ahn
Kay Ahn is a scholar working on Pharmacology, Biochemistry, Computational Theory and Mathematics, Organic Chemistry and Molecular Biology, having authored 31 papers that have together received 3.2k indexed citations. Recurring topics across this work include Cannabis and Cannabinoid Research (9 papers), Lipid metabolism and biosynthesis (5 papers), Computational Drug Discovery Methods (5 papers), Protein Degradation and Inhibitors (4 papers), Protein Kinase Regulation and GTPase Signaling (3 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (3 papers), Synthesis and biological activity (3 papers) and Inflammatory mediators and NSAID effects (2 papers). The work is most often cited by research in Geriatrics and Gerontology (480 citations), Pharmacology (1.2k citations), Aging (61 citations), Biochemistry (134 citations) and Organic Chemistry (333 citations). Kay Ahn has collaborated with scholars based in United States and Belgium. Frequent co-authors include Benjamin F. Cravatt, Michele K. McKinney, Douglas S. Johnson, Brandon A. Pabst, Marya B. Liimatta, Robert S. Garofalo, Michelle Pacholec, Cory M. Stiff, Brian J. Stockman and Venkataraman Thanabal. Their work appears in journals such as Journal of Medicinal Chemistry, Biochemistry, Journal of Pharmacology and Experimental Therapeutics, ACS Medicinal Chemistry Letters and Bioorganic & Medicinal Chemistry Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.